Neogen Corp (NEOG): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$116.30M
Year ended 2026-05-31
+9.6%
3-year compound annual growth
+40.8%
5-year compound annual growth
+25.3%
10-year compound annual growth
$119.50M2010-05-31: $4.43M2011-05-31: $5.33M2012-05-31: $6.17M2013-05-31: $7.41M2014-05-31: $9.18M2015-05-31: $10.65M2016-05-31: $12.18M2017-05-31: $14.69M2018-05-31: $17.06M2019-05-31: $17.62M2020-05-31: $18.40M2021-05-31: $21.04M2022-05-31: $23.69M2023-05-31: $88.38M2024-05-31: $116.70M2025-05-31: $119.50M2026-05-31: $116.30M$116.30M
2010-05-31 Depreciation & Amortization (USD) 2026-05-31
Period endedDepreciation & AmortizationChange YoYSource filing
2026-05-31$116.30M-2.7%2026-07-30, From 2025-06-01
2025-05-31$119.50M+2.4%2026-07-30, From 2024-06-01
2024-05-31$116.70M+32.0%2026-07-30, From 2023-06-01
2023-05-31$88.38M+273.0%2025-07-30, From 2022-06-01
2022-05-31$23.69M+12.6%2024-07-30, From 2021-06-01
2021-05-31$21.04M+14.4%2023-08-15, From 2020-06-01
2020-05-31$18.40M+4.4%2022-07-27, From 2019-06-01
2019-05-31$17.62M+3.3%2021-07-30, From 2018-06-01
2018-05-31$17.06M+16.1%2020-07-30, From 2017-06-01
2017-05-31$14.69M+20.6%2019-07-30, From 2016-06-01
2016-05-31$12.18M+14.4%2018-07-27, From 2015-06-01
2015-05-31$10.65M+16.0%2017-07-28, From 2014-06-01
2014-05-31$9.18M+23.9%2016-07-29, From 2013-06-01
2013-05-31$7.41M+20.1%2015-07-30, From 2012-06-01
2012-05-31$6.17M+15.8%2014-07-30, From 2011-06-01
2011-05-31$5.33M+20.2%2013-07-30, From 2010-06-01
2010-05-31$4.43Mn/a2012-07-30, From 2009-06-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Neogen Corp (NEOG)2026-05-31$116.30M-2.7%
Myriad Genetics Inc (MYGN)2025-12-31$53.70M-12.3%
Lantheus Holdings, Inc. (LNTH)2025-12-31$70.10M+8.5%
QuidelOrtho Corp (QDEL)2025-12-28$442.00M-2.5%
Idexx Laboratories Inc (IDXX)2025-12-31$145.18M+11.7%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$9.77M-5.0%
Alpha Teknova, Inc. (TKNO)2025-12-31$6.34M-3.6%
Immucell Corp (ICCC)2025-12-31$2.78M+2.0%
Aspira Women's Health Inc. (AWHL)2025-12-31$112.0K+21.7%

Compare NEOG, MYGN, LNTH, QDEL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗